sur The Vanguard Group, Inc. (isin : US12572Q1058)
Vanguard Group Discloses Position in Mural Oncology
The Vanguard Group, Inc. has released a Form 8.3 under the Irish Takeover Panel Act concerning its position in Mural Oncology plc. The disclosure, dated July 17, 2025, indicates Vanguard's interests in Mural Oncology with a holding of 772,579 ordinary shares, equivalent to 4.47% of the company.
Vanguard reported no dealings in derivatives or options relating to the shares of Mural Oncology. Additionally, there were no agreements or understandings concerning the voting rights of the securities or future acquisitions. The company also confirmed that no indemnity or other dealing arrangements exist.
No supplemental Form 8 accompanies this disclosure, which specifies a minor sale of 16 shares at $2.49 each. This position disclosure aligns with Rule 8.3 of the Irish Takeover Panel, aiming for transparency in corporate acquisitions.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.